176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.98%
Revenue growth at 75-90% of INTC's 11.59%. Bill Ackman would push for innovation or market expansion to catch up.
49.12%
Gross profit growth above 1.5x INTC's 21.90%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
241.17%
EBIT growth above 1.5x INTC's 11.20%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
241.17%
Operating income growth above 1.5x INTC's 11.20%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
204.73%
Net income growth above 1.5x INTC's 31.14%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
196.15%
EPS growth above 1.5x INTC's 32.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
196.15%
Diluted EPS growth above 1.5x INTC's 28.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
9.26%
Slight or no buybacks while INTC is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
9.26%
Diluted share count expanding well above INTC's 0.69%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
36.23%
OCF growth 1.25-1.5x INTC's 24.47%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
31.32%
FCF growth 50-75% of INTC's 54.11%. Martin Whitman would see if structural disadvantages exist in generating free cash.
227.44%
10Y revenue/share CAGR at 75-90% of INTC's 264.84%. Bill Ackman would press for new markets or product lines to narrow the gap.
227.44%
5Y revenue/share CAGR above 1.5x INTC's 24.04%. David Dodd would look for consistent product or market expansions fueling outperformance.
227.44%
3Y revenue/share CAGR above 1.5x INTC's 3.79%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
2003.06%
10Y OCF/share CAGR above 1.5x INTC's 351.15%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2003.06%
5Y OCF/share CAGR above 1.5x INTC's 14.94%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
2003.06%
3Y OCF/share CAGR above 1.5x INTC's 21.38%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
212.78%
Net income/share CAGR at 75-90% of INTC's 264.71%. Bill Ackman would press for strategic moves to boost long-term earnings.
212.78%
5Y net income/share CAGR above 1.5x INTC's 13.75%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
212.78%
3Y net income/share CAGR above 1.5x INTC's 2.39%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
571.10%
10Y equity/share CAGR 1.25-1.5x INTC's 403.17%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
571.10%
5Y equity/share CAGR above 1.5x INTC's 74.92%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
571.10%
3Y equity/share CAGR above 1.5x INTC's 4.78%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.10%
Our AR growth while INTC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-29.26%
Inventory is declining while INTC stands at 13.21%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.78%
Negative asset growth while INTC invests at 0.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.92%
We have a declining book value while INTC shows 1.38%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.44%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.70%
Our R&D shrinks while INTC invests at 3.70%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
145.70%
SG&A growth well above INTC's 8.51%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.